Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 5Phase 1/2 3Phase 3 2

Status

Recruiting 1Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Burkitt Lymphoma 9Leukemia 6Recurrence 4Lymphoma 4Prostatic Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Biphenotypic, Acute 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms, Plasma Cell 2Immunoglobulin Light-chain Amyloidosis 2Hodgkin Disease 2Down Syndrome 2Breast Neoplasms 2Vomiting 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Smoldering Multiple Myeloma 1Nausea 1Malignant Neoplasms of Male Genital Organs 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Inflammatory Breast Neoplasms 1Hypersensitivity 1Hematologic Neoplasms 1Hematologic Diseases 1

Interventions

Melphalan 8Dexamethasone 7Bortezomib 6Filgrastim 4Cyclophosphamide 3liposomal amphotericin B 2Early Intervention, Educational 2Darbepoetin alfa 2Clinical Protocols 2Calcium Dobesilate 2ferrous sulfate 1ferric gluconate 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1birtamimab 1auricularum 1Sucrose 1Stem Cell Transplantation 1Specimen Handling 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Ondansetron 1Morphine 1Magnetic Resonance Spectroscopy 1Ketamine 1Hypericum extract LI 160 1Granulocyte Colony-Stimulating Factor 1Fentanyl 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Immunoglobulin Light-chain Amyloidosis × Calcium Dobesilate × Clear all
NCT06022939 2026-05-06

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

SWOG Cancer Research Network

Phase 3 Recruiting
338 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT01078454 2022-02-01

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

National Cancer Institute (NCI)

Phase 3 Completed
11 enrolled 6 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡